Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2021-05-01
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Lowering IOP in Glaucoma Suspects With HM
NCT04296916
Effect of Metformin on Visual Function in Patients With Glaucoma
NCT04155164
Clinical Characteristics of Neovascular Glaucoma
NCT07177807
The Study of Ocular Hemodynamics With Glaucoma Progression
NCT01145911
Minimally Invasive Suprachoroidal Drainage for the Treatment of Neovascular Glaucoma
NCT07201415
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
healthy control
adults without glaucoma history or hypertension history
no intervention
no intervention, only measurement of blood pressure, intraocular pressure, hypertensive history questionnaire, retinal imaging, optical coherence tomography examination etc..
glaucoma patients
adults with primary glaucoma history; without glaucoma-related operation history; without hypertension history
no intervention
no intervention, only measurement of blood pressure, intraocular pressure, hypertensive history questionnaire, retinal imaging, optical coherence tomography examination etc..
hypertension patients
adults with primary hypertension history; without glaucoma history
no intervention
no intervention, only measurement of blood pressure, intraocular pressure, hypertensive history questionnaire, retinal imaging, optical coherence tomography examination etc..
glaucoma+hypertension
adults with primary glaucoma history and primary hypertension history; without glaucoma-related operation history
no intervention
no intervention, only measurement of blood pressure, intraocular pressure, hypertensive history questionnaire, retinal imaging, optical coherence tomography examination etc..
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no intervention
no intervention, only measurement of blood pressure, intraocular pressure, hypertensive history questionnaire, retinal imaging, optical coherence tomography examination etc..
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* best corrected visual acuity better than decimal 0.3
Exclusion Criteria
* secondary hypertension
* glaucoma-related operation history
* pregnancy or lactation period
* uncooperative with retinal examination
* severe opacity with refracting media in eye
* severe retinal diseases and neuropathy
* congenital retinal optic nerve abnormality
* other systemic diseases that influence hypertension and glaucoma assessment
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kaijun Wang, MD
Role: PRINCIPAL_INVESTIGATOR
Second Affiliated Hospital of College of Medicine, Zhejiang University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-0287
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.